Sorry, nothing in cart.
Blog
Ivermectin and Albendazole FAQs: Combination and Product Differences
Ivermectin/albendazole may refer to a fixed-combination product or two separate medicines. Those descriptions are not interchangeable. Updated 29 October 2026.
Is there a fixed-combination medicine?
EMA issued a positive scientific opinion for a specific orodispersible ivermectin/albendazole product for use outside the EU. That opinion does not verify every combination brand or establish Australian approval.
What infections does that assessment cover?
The assessed product covers specified intestinal helminth infections and microfilaraemia from Wuchereria bancrofti. Its official guidance and exact leaflet determine the applicable use.
Is public-health treatment the same as my prescription?
No. WHO mass-treatment programmes use setting-specific regimens that depend on other infections present locally. A programme schedule is not a self-treatment plan.
What should I tell my clinician?
Discuss pregnancy or pregnancy plans, liver problems, other medicines and possible exposure to Loa loa. These can affect risk and treatment decisions.
Can I combine two tablets myself?
Do not infer a course from the ingredient names. A prescriber must specify the formulation, strengths and instructions; an orodispersible fixed combination is not automatically equivalent to separately purchased tablets.
Where can I read about albendazole alone?
See our albendazole FAQs. Information about either ingredient alone does not establish the safety of a particular combination.
Sources: EMA: Ivermectin/Albendazole and WHO: Lymphatic filariasis. This is general education, not an individual treatment plan or verification of a particular brand.
Explore our Health Guides. For website and order enquiries, visit support FAQs or contact support.
